Z-Medica and OxySure Sign Distribution Agreement

Share Article

Z-Medica® LLC, announces that they have signed a distribution agreement with OxySure to sell QuikClot® products to their customers.

Z-Medica® LLC, a leading developer and marketer of hemostatic devices, announces today that they have signed a distribution agreement with OxySure Systems, Inc. (OTCQB: OXYS), a global leader and innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical device solutions, to sell QuikClot® products to their customers.

“The product lines of Z-Medica and OxySure run parallel in that both companies create medical devices that can save lives when minutes count,” said Stephen J. Fanning, President and CEO of Z-Medica. “We look forward to partnering with OxySure and expanding our distribution channels to fulfill unmet public safety needs.”

“We are pleased to add QuikClot to our current emergency medical and resuscitation product offerings,” said Clark Hood, Vice President of Resuscitation Sales for OxySure. “We believe this is another significant milestone in our mission to become a leading supplier of critical life-saving emergency response products in the first responder, school and public access markets. Adding QuikClot to our current Model 615 emergency oxygen system and automated external defibrillator (AED) offerings is a natural fit for our organization.”

About Z-Medica®, LLC
Z-Medica, LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostatic products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) chose QuikClot Combat Gauze® as the hemostatic dressing of choice on the battlefield for compressible hemorrhage not amenable to tourniquet use or as an adjunct to tourniquet removal if evacuation time is anticipated to be longer than 2 hours. QuikClot® products are developed and manufactured in the United States. Z-Medica, LLC is a privately-held company based in Wallingford, CT. For more information, visit http://www.quikclot.com

About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. http://www.OxySure.com


For Z-Medica:     Dave Schemelia / EVC Group
dave(at)evcgoup.com / 609-468-9325

For OxySure:    Investor Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
Richard Dupuy: rdupuy(at)renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989

Redchip Companies, Inc.         
Jon Cunningham: jon(at)redchip.com    
800-733-2447, ext. 107        


Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Dave Schemelia
EVC Group
+1 (609) 468-9325
Email >